You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Brachyury

Showing 1 - 25 of 40
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Prostate Cancer, Prostate Cancer, Prostate Tumor Trial run by the NCI (M7824, N-803, MVA-BN-Brachyury)

Recruiting
  • Metastatic Prostate Cancer
  • +4 more
  • M7824
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Castration Resistant Prostate Cancer Trial run by the National Cancer Institute (NCI) (Bintrafusp alfa, N-803, BN-Brachyury)

Not yet recruiting
  • Castration Resistant Prostate Cancer
  • Bintrafusp alfa
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Chordoma Trial in United States (BN-Brachyury plus radiation)

Completed
  • Chordoma
  • BN-Brachyury plus radiation
  • Phoenix, Arizona
  • +4 more
Feb 25, 2022

Breast Cancer, Triple Negative Breast Cancer, HER2+ Breast Cancer Trial run by the NCI (Brachyury-TRICOM, Entinostat, M7824)

Terminated
Has Results
  • Breast Cancer
  • +4 more
  • Brachyury-TRICOM
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 9, 2021

Prostate Adenocarcinoma Trial in Salt Lake City (MVA-BN-Brachyury)

Withdrawn
  • Prostate Adenocarcinoma
  • MVA-BN-Brachyury
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Sep 21, 2021

Solid Metastatic Tumor Trial run by the (MVA-BN-Brachyury)

Completed
  • Solid Metastatic Tumor
  • MVA-BN-Brachyury
  • Bethesda, Maryland
    National Cancer Institute
Jul 8, 2021

Metastatic Colorectal Cancer Trial run by the National Cancer Institute (NCI) (Retifanlimab, Therapeutic CEA, Brachyury and MUC1

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 4, 2023

Prostatic Tumors, Prostatic Cancer Trial run by the NCI (ETBX-071; adenoviral PSA vaccine, ETBX-061; adenoviral MUC1 vaccine,

Completed
Has Results
  • Prostatic Neoplasms
  • Prostatic Cancer
  • ETBX-071; adenoviral PSA vaccine
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 28, 2021

Chordoma, Breast Cancer, Gastric/Gastroesophageal Junction Cancer Trial in United States (TAEK-VAC-HerBy)

Recruiting
  • Chordoma
  • +2 more
  • TAEK-VAC-HerBy
  • Scottsdale, Arizona
  • +8 more
Oct 27, 2022

Lung Cancer, Breast Cancer, Prostate Cancer Trial run by the NCI (MVA-brachyury- TRICOM)

Completed
Has Results
  • Lung Cancer
  • +4 more
  • MVA-brachyury- TRICOM
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 11, 2021

Safety Issues Trial run by the (MVA-BN-Brachyury/ FPV-Brachyury)

Completed
  • Safety Issues
  • MVA-BN-Brachyury/ FPV-Brachyury
  • Bethesda, Maryland
    Genitourinary Malignancies Branch National Cancer Institute
Aug 25, 2020

Tumors, Prostate Cancer, Lung Cancer Trial run by the NCI (ETBX-051; adenoviral brachyury vaccine, ETBX-061; adenoviral Mucin-1

Completed
Has Results
  • Neoplasms
  • +4 more
  • ETBX-051; adenoviral brachyury vaccine
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 25, 2020

Lynch Syndrome Trial in Puerto Rico, United States (procedure, drug, other, biological)

Not yet recruiting
  • Lynch Syndrome
  • Biopsy
  • +5 more
  • Phoenix, Arizona
  • +13 more
Sep 16, 2022

Chordoma Trial run by the (other, biological, radiation, device)

Unknown status
  • Chordoma
  • GI-6301 Placebo
  • +3 more
  • Bethesda, Maryland
    NIH Clinical Center
Oct 22, 2019

A Protocol to Identify Sporadic Chordoma Studies of

Recruiting
  • Genes
  • Sporadic Chordoma
    • Rockville, Maryland
      Westat, Inc.
    Aug 20, 2022

    Non Small Cell Lung Cancer Trial in El Segundo (Nab-paclitaxel, Cisplatin, 5Fluorouracil)

    Withdrawn
    • Non Small Cell Lung Cancer
    • El Segundo, California
      Chan Soon-Shiong Institute for Medicine
    Mar 28, 2022

    Colorectal Cancer Metastatic, mCRC Trial in El Segundo (biological, drug, procedure)

    Active, not recruiting
    • Colorectal Cancer Metastatic
    • mCRC
    • Aldoxorubicin Hydrochloride
    • +19 more
    • El Segundo, California
      Chan Soon-Shiong Institute for Medicine
    Mar 28, 2022

    Triple Negative Breast Cancer (TNBC) Trial in El Segundo (Leucovorin, 5-Fluorouracil, Aldoxorubicin HCl)

    Withdrawn
    • Triple Negative Breast Cancer (TNBC)
    • El Segundo, California
      Chan Soon-Shiong Institute for Medicine
    Mar 28, 2022

    Triple Negative Breast Cancer Trial in El Segundo (drug, biological, procedure)

    Active, not recruiting
    • Triple Negative Breast Cancer
    • Aldoxorubicin HCl
    • +17 more
    • El Segundo, California
      Chan Soon-Shiong Institute for Medicine
    Mar 28, 2022

    Chordoma, Chemo Effect Trial in Beijing (camrelizumab and apatinib)

    Recruiting
    • Chordoma
    • Chemotherapy Effect
    • camrelizumab and apatinib
    • Beijing, Beijing, China
      BEIJING
    Nov 14, 2023

    Chordoma Trial in Worldwide (Randomized Cohort, Prospective cohort)

    Recruiting
    • Chordoma
    • Randomized Cohort
    • Prospective cohort
    • Graz, Austria
    • +27 more
    Oct 29, 2021

    Merkel Cell Carcinoma Trial (biological, drug, radiation)

    Withdrawn
    • Merkel Cell Carcinoma
    • Avelumab
    • +14 more
    • (no location specified)
    Mar 17, 2021

    Chordoma, Unresectable Malignant Tumor Trial in El Segundo (biological, drug, radiation)

    Withdrawn
    • Chordoma
    • Unresectable Malignant Neoplasm
    • Aldoxorubicin Hydrochloride
    • +9 more
    • El Segundo, California
      Chan Soon-Shiong Institute for Medicine
    Mar 17, 2021

    Melanoma Trial (biological, drug, radiation)

    Withdrawn
    • Melanoma
    • Avelumab
    • +17 more
    • (no location specified)
    Mar 17, 2021

    Triple Negative Breast Cancer Trial (biological, drug, radiation)

    Withdrawn
    • Triple Negative Breast Cancer
    • avelumab
    • +17 more
    • (no location specified)
    Mar 17, 2021